| Net Cash Provided by (Used in) Operating Activities |
$1,735 |
USD |
63% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$3,000 |
USD |
-25% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
10,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,265 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,185 |
USD |
-28% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Additional Paid in Capital |
$64,700 |
USD |
13% |
Q4 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
Q2 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |